ImmunoPrecise Antibodies Ltd. (HYFT) — Financial Flexibility Index
ImmunoPrecise Antibodies Ltd. (HYFT) has a Financial Flexibility Index of -0.33x as of October 2025. Free cash flow of $-2.80 Million (operating CF $-2.87 Million minus capex $74.00K) represents 0% of total liabilities ($8.40 Million). Also explore ImmunoPrecise Antibodies Ltd. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ImmunoPrecise Antibodies Ltd. Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for ImmunoPrecise Antibodies Ltd. across 29 annual periods. Check how strategically is ImmunoPrecise Antibodies Ltd.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ImmunoPrecise Antibodies Ltd. (1997–2025)
Year-by-year free cash flow to debt coverage for ImmunoPrecise Antibodies Ltd.. For the full company profile including market capitalisation, see HYFT stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -94.2% |
| 2022 | -0.47x | $-8.66 Million | $-9.92 Million | $18.36 Million | ▼ -672.5% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▲ +21.5% |
| 2011 | -0.78x | $-66.73K | $-80.39K | $85.19K | ▼ -649.7% |
| 2010 | 0.14x | $14.32K | $-308.49K | $100.47K | ▼ -98.3% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -214.0% |
| 2007 | 9.80x | $1.53 Million | $-297.31K | $155.85K | ▼ -21.8% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +231.8% |
| 2003 | -1.18x | $-18.95K | $-168.38K | $16.02K | ▲ +18.2% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |